Ronald Orol leads The Deal's coverage of activist hedge fund managers, a high-profile group of corporate investors who press for blockbuster deals and were the subject of his book “Extreme Value Hedging: How Activist Hedge Fund Managers are Taking on the World.” Orol also specializes in reporting on bank and securities regulation in the wake of the 2008 financial crisis. Orol’s reporting covers a wide range of Washington issues critical to dealmaking, including financial reform, Securities and Exchange Commission rules impacting IPOs and mergers and federal oversight of bank transactions. Orol is an occasional commentator on TheStreet TV, BBC World Television and National Public Radio.
Recent Articles By The Author
ISS, Glass Lewis Oppose Facebook Directors
Institutional Shareholder Services recommended that investors vote no in an uncontested election against five of nine Facebook directors, including the company's founder, Mark Zuckerberg, who holds the chairman position.
Starboard Quadruples Holding in Macerich, Weighs Director Contest
The Deal has learned that Third Point's Dan Loeb has liquidated his position in the shopping mall developer, a possible blow to Jeff Smith's efforts.
Activist Fund Engaged Takes New Position in Cross Country Health
Glenn Welling took a couple new stakes and maintained large stakes at key targets including Rent-A-Center, Hain Celestial and TiVo.
Activist Elliott Management Buys Dish, Exxon, and Ford Stakes
Here's a wrap-up of new investments by the insurgent fund, as well as the latest stakes accumulated by Corvex's Keith Meister and a new investment by Bill Ackman.
Jana Partners Takes Positions in Adobe, Apple, Anthem, AutoDesk, Others
The insurgent manager who helped engineer the Amazon-Whole Foods combination opened a window into his latest allocations, any of which could become campaigns. Here's a wrap up of his investments as well as new developments from Mick McGuire's Marcato Capital and Dan Loeb's Third Point.
Nelson Peltz Is In a League of His Own When it Comes to Activist Investing
The 'highly-engaged' activist investor uses operational expertise and PE-style attitude to go after companies many activists avoid.
Xerox Boots CEO In Deal With Activist Investor Carl Icahn
The document technology company also agreed to bring on five dissident directors and replace its CEO. Six existing board members also resigned in a resounding victory for the dissident investors.
Former Starbucks CEO Schultz: U.S. People Are Better Than Our 'Political Class'
Former Starbucks CEO Howard Schultz slammed politicians on Thursday during an event in Washington, DC.
Athenahealth Shares Explode Higher on Latest Elliott Management Bid
The insurgent fund managed by Paul Singer wants to buy the health tech company for $6.9 billion, but its large minority stake suggests that the fund would not be disappointed if a White Knight buyer emerged.
Xerox Ousts CEO In Deal With Icahn
The billionaire known by some as the "CEO slayer" reached a deal with the document technology company that included the installation of six new directors.